According to Sonoma Pharmaceuticals's latest financial reports the company has NZ$8.99 Million in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-03-31 | NZ$5.22 M | -14.34% |
2023-03-31 | NZ$6.09 M | -42.82% |
2022-03-31 | NZ$10.66 M | 76.51% |
2021-03-31 | NZ$6.04 M | -2.57% |
2020-03-31 | NZ$6.2 M | 14.73% |
2019-03-31 | NZ$5.4 M | -61.14% |
2018-03-31 | NZ$13.91 M | -44.12% |
2017-03-31 | NZ$24.89 M | 130.69% |
2016-03-31 | NZ$10.79 M | 30.95% |
2015-03-31 | NZ$8.24 M | 30.49% |
2014-03-31 | NZ$6.31 M | -33.03% |
2013-03-31 | NZ$9.43 M | 131.03% |
2012-03-31 | NZ$4.08 M | -28.96% |
2011-03-31 | NZ$5.74 M | -35.01% |
2010-03-31 | NZ$8.84 M | 160.97% |
2009-03-31 | NZ$3.38 M | -85.53% |
2008-03-31 | NZ$23.41 M | -12.06% |
2007-03-31 | NZ$26.62 M | 116.34% |
2006-03-31 | NZ$12.3 M | 166.33% |
2005-03-31 | NZ$4.62 M | |
2003-03-31 | NZ$0.31 M | -81.56% |
2002-03-31 | NZ$1.73 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() Onconova Therapeutics ONTX | NZ$27.44 M | 204.99% | ๐บ๐ธ USA |
![]() OPKO Health
OPK | NZ$0.73 B | 8,013.12% | ๐บ๐ธ USA |